Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02701270 |
|
Recruitment Status :
Completed
First Posted : March 8, 2016
Results First Posted : July 27, 2016
Last Update Posted : July 27, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Healthy Volunteers | Dietary Supplement: Experimental Dietary Fibre 1 Dietary Supplement: Experimental Dietary Fibre 2 Dietary Supplement: Polydextrose Dietary Supplement: Dextrose | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 13 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Single (Participant) |
| Official Title: | Randomised, Single-blinded, Controlled, Crossover and Acute Clinical Intervention to Assess the Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers |
| Study Start Date : | September 2015 |
| Actual Primary Completion Date : | October 2015 |
| Actual Study Completion Date : | October 2015 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: Experimental Dietary Fibre 1 |
Dietary Supplement: Experimental Dietary Fibre 1
22.17 g of product diluted in 250 ml of water taken once orally. |
| Experimental: Experimental Dietary Fibre 2 |
Dietary Supplement: Experimental Dietary Fibre 2
21.84 g of product diluted in 250 ml of water taken once orally. |
| Active Comparator: Polydextrose |
Dietary Supplement: Polydextrose
21.48 g of product diluted in 250 ml of water taken once orally. |
| Active Comparator: Dextrose control |
Dietary Supplement: Dextrose
23.89 g of dextrose diluted in 250 ml of water taken once orally. |
- Assessment of IAUC (Incremental Area Under the Curve) in Blood Glucose Response [ Time Frame: 0, 15, 30, 45, 60, 90, 120, 150, 180, 210 and 240 minutes post dose ]
- Assessment of IAUC (Incremental Area Under the Curve) in Blood Insulin Response [ Time Frame: 0, 15, 30, 45, 60, 90, 120, 150, 180, 210 and 240 minutes post dose ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- BMI between 18-27 kg/m2.
- Self-diagnosed as healthy at the time of recruitment, confirmed by medical questionnaire: no reported current or previous metabolic diseases or chronic gastrointestinal disorders.
- No blood donations during the study.
- Reported intense sporting activities < 10hr/w.
- Reported alcohol consumption ≤21 units/w (female volunteers) or ≤28 units/w (male volunteers).
- Feasibility to give blood sample as per study protocol.
- Informed consent signed
Exclusion Criteria:
- Dislike, allergy or intolerance to test products.
- Fasting blood glucose levels <4.4 or >6.1.
- Volunteer has any health conditions that would prevent him/her from fulfilling the study requirements, put the subject at risk or would confound the interpretation of the study results as judged by the Principal Investigator.
- Volunteer with history of diabetes and high blood pressure.
- Having consumed anything apart from plain water in the twelve hours prior to the first test day.
- Volunteer and/or immediate family member is an employee of the investigational site directly affiliated with this study, the sponsor or the clinical research organization.
- Reported lactating (or lactating < 6 weeks ago), pregnant (or pregnant < 3 months ago) or wish to become pregnant during the study.
- Reported participation in another biomedical trial 1 month before the start of the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02701270
| United Kingdom | |
| Leatherhead Food Research | |
| Leatherhead, United Kingdom, KT22 7RY | |
| Responsible Party: | Danisco |
| ClinicalTrials.gov Identifier: | NCT02701270 |
| Other Study ID Numbers: |
111031-DP-2015-06-26 |
| First Posted: | March 8, 2016 Key Record Dates |
| Results First Posted: | July 27, 2016 |
| Last Update Posted: | July 27, 2016 |
| Last Verified: | June 2016 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Glycemic Index Dietary Fiber |

